Powered by
Immunotec in 2nd consecutive rise, nears five-month high February 27, 2017 17:00 EST
Feb 27, 2017 - News Bites Canadian Markets


Immunotec Inc. (TSXV:IMM), Canada's 6th largest Medical diagnostics & research company by market cap, extended its gains on Monday, rising an additional 1.0c (2.6%) to trade at 40.0c. The stock lifted 2.6% on Friday. This brought its 2-day rise to 5.3%, compared with the S&P/TSX 60 Index which fell 17.7 points (1.9%) in the two days for a relative price increase of 7.2%. Volume in the 2 days was 0.9 times the average daily volume of 21,250 shares. The stock is n

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox